Traders sold shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on strength during trading on Thursday after Needham & lowered their price target on the stock to $86.00. $54.20 million flowed into the stock on the tick-up and $83.27 million flowed out of the stock on the tick-down, for a money net flow of $29.07 million out of the stock. Of all companies tracked, Walgreens Boots Alliance had the 12th highest net out-flow for the day. Walgreens Boots Alliance traded up $0.17 for the day and closed at $71.33

Several other research analysts also recently weighed in on the company. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Royal Bank Of Canada initiated coverage on Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 target price on the stock. Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup Inc. dropped their target price on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $87.21.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by insiders.

A number of institutional investors have recently bought and sold shares of WBA. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the last quarter. Westside Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 125 shares during the last quarter. Zions Bancorporation boosted its stake in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,239 shares during the last quarter. Reilly Financial Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after buying an additional 100 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 2,199 shares during the last quarter. Institutional investors and hedge funds own 63.35% of the company’s stock.

The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. The company has a market capitalization of $71,839.51, a P/E ratio of 13.95, a P/E/G ratio of 1.27 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the prior year, the business earned $1.07 earnings per share. The company’s revenue was up 5.3% compared to the same quarter last year. equities analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be paid a $0.40 dividend. The ex-dividend date is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Walgreens Boots Alliance’s payout ratio is 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has approved a share repurchase program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s leadership believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: “Traders Sell Walgreens Boots Alliance, Inc. (WBA) on Strength After Analyst Downgrade” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/11/23/traders-sell-walgreens-boots-alliance-inc-wba-on-strength-after-analyst-downgrade.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.